Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Osvix for tinnitus and headache in patients with transverse venous sinus stenosis or hypoplasia
IRCT20220715055474N1Phase 3Completed
- Sponsor
- Aja University of Medical Sciences
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of clopidogrel in transverse sinus stenosis (TSS) and Transverse venous sinus hypoplasia (TVSH), sponsored by Aja University of Medical Sciences. Primary endpoints: Reduction in tinnitus sensation and Reduction in headache. Started May 2023; status: completed.
02
Drugs
clopidogrel
03
Conditions
transverse sinus stenosis (TSS)Transverse venous sinus hypoplasia (TVSH)
Beyond the preview
Go deeper on IRCT20220715055474N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220715055474N1.